SCHEMBL350219

SCHEMBL350219

C=CCOCC(=C)C(=O)OCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
TSHR P16473 2/20 0.40
NPSR1 Q6W5P4 1/20 0.37
GLO1 Q04760 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
THRB P10828 1/20 0.35
MAPT P10636 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.32
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP2C9 P11712 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
ALOX15 P16050 1/20 0.31
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28903556 0.91 TDP1 (0.41) ALDH1A1TSHRNPSR1GLO1TDP1
SCHEMBL352550 0.86 TDP1 (0.40) ALDH1A1TSHRNPSR1TDP1MAPT
SCHEMBL352472 0.86 THRB (0.54) ALDH1A1TSHRTDP1THRBMEN1
SCHEMBL353022 0.86 TDP1 (0.38) ALDH1A1TSHRTDP1THRBSMN1; SMN2
SCHEMBL352988 0.85 THRB (0.53) ALDH1A1TSHRTDP1THRBMEN1
SCHEMBL1520965 0.84 ALDH1A1 (0.48) ALDH1A1TSHRNPSR1GLO1THRB
SCHEMBL352761 0.83 TSHR (0.47) ALDH1A1TSHRNPSR1TDP1THRB
SCHEMBL4087701 0.82 ALDH1A1 (0.47) ALDH1A1TSHRNPSR1GLO1THRB
SCHEMBL25803017 0.82 THRB (0.43) ALDH1A1TSHRTDP1THRBSMN1; SMN2
SCHEMBL351664 0.82 TSHR (0.51) ALDH1A1TSHRNPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11987658-B2 Curable resin composition and method of manufacturing article CANON KABUSHIKI KAISHA (JP) 2024-05-21 US claimed
US-20220282013-A1 CURABLE RESIN COMPOSITION AND METHOD OF MANUFACTURING ARTICLE CANON KABUSHIKI KAISHA (JP) 2022-09-08 US claimed
WO-2020162475-A1 CURABLE RESIN COMPOSITION キヤノン株式会社 2020-08-13 WO claimed
WO-2026105125-A1 FORMULATIONS USABLE IN ADDITIVE MANUFACTURING OF THREE-DIMENSIONAL OBJECTS STRATASYS LTD. (IL) 2026-05-21 WO disclosed
CN-115362184-B Curable composition, cured product, and electronic component 太阳控股株式会社 2024-07-12 CN disclosed
WO-2024128086-A1 CURABLE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING LAMINATE 富士フイルム株式会社 2024-06-20 WO disclosed
US-11987658-B2 Curable resin composition and method of manufacturing article CANON KABUSHIKI KAISHA (JP) 2024-05-21 US disclosed
CN-111849361-B Adhesive composition for optical use, and adhesive film and adhesive sheet each using the same 藤森工业株式会社 2024-01-12 CN disclosed
WO-2023248976-A1 POLYMER AND METHOD FOR PRODUCING SAME, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, AND MONOMER COMPOUND AND METHOD FOR PRODUCING SAME 株式会社日本触媒 2023-12-28 WO disclosed
WO-2023189284-A1 PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND PRESSURE-SENSITIVE ADHESIVE SHEET 王子ホールディングス株式会社 2023-10-05 WO disclosed
WO-2023167187-A1 POLYMERIZABLE COMPOSITION 株式会社日本触媒 2023-09-07 WO disclosed
CN-111542554-A Polymer, curable resin composition, and use thereof 株式会社日本触媒 2020-08-14 CN disclosed
US-10449124-B2 Polymerizable composition for dental use GC CORPORATION (JP) 2019-10-22 US disclosed
US-20180221251-A1 POLYMERIZABLE COMPOSITION FOR DENTAL USE GC CORPORATION (JP) 2018-08-09 US disclosed
EP-3335688-A1 POLYMERIZABLE DENTAL COMPOSITION GC Corporation (JP) 2018-06-20 EP disclosed
US-20180037758-A1 Ink Composition For Three-Dimensional Modeling, Ink Set, And Method For Producing Three-Dimensional Model Konica Minolta, Inc. (JP) 2018-02-08 US disclosed
EP-2415751-B1 ALPHA-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF NIPPON CATALYTIC CHEM IND (JP) 2014-11-26 EP disclosed
US-8796492-B2 α-(unsaturated alkoxyalkyl) acrylate composition and process for production thereof NIPPON SHOKUBAI CO., LTD. (JP) 2014-08-05 US disclosed
EP-2415751-A1 ALPHA-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF Nippon Shokubai Co., Ltd. (JP) 2012-02-08 EP disclosed
US-20120016095-A1 a-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180221251-A1 POLYMERIZABLE COMPOSITION FOR DENTAL USE CAD, MDN1, PAM ALDH1A1 1401/4885TSHR 4579/4885NPSR1 4550/4885
US-10449124-B2 Polymerizable composition for dental use CAD, MDN1, PAM ALDH1A1 1401/4885TSHR 4579/4885NPSR1 4550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.